Stem cell nasal spray for autoimmune encephalitis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests whether a nasal spray containing stem cell products can help people recover from autoimmune encephalitis, a condition where the body's immune system attacks the brain. It may reduce symptoms like confusion, memory problems, or seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You were diagnosed with autoimmune encephalitis within the last 3 months
- You have anti-NMDAR or anti-LGI1 antibodies in your blood or spinal fluid
- Your current condition makes it hard to do daily tasks (score of 2 or more on a disability scale)
- You are willing to use contraception during the study
- You do not have other serious health problems (like heart, liver, or kidney disease) or active infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
This study collects health information from people with autoimmune encephalitis, a condition where the body's immune system attacks the brain. It aims to understand the disease better, and if you have seizures from it, you can join a special epilepsy part.
This trial tests a new type of immune cell therapy (CAR T-cells) that targets CD19 and BCMA proteins on B cells. It is for people with certain neurological autoimmune diseases that have come back or not responded to standard treatments. The goal is to see if this therapy can help control the disease.
This study tests a natural bile-derived medicine (Calcus Bovis Sativus) to see if it can help adults with new or recent brain inflammation (encephalitis). It focuses on people whose encephalitis is caused by the immune system or a virus, and who have not fully recovered.
This Phase 2 study tests inebilizumab in people with NMDA receptor encephalitis, an immune-related brain condition. It looks to see if adding this treatment after starting steroids (and possibly other first treatments) improves recovery and safety.
This trial tests an investigational drug called CTA313 in people with certain autoimmune diseases that haven't improved with other treatments. It aims to see if the drug can help control the disease.
Hear when a new Autoimmune Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.